Veterinary Medicines

NOBILIS IB MULTI+ND+EDS ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Authorised
  • Eggdrop syndrome-1976 virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
NOBILIS IB MULTI+ND+EDS ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Eggdrop syndrome-1976 virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, Inactivated
    6.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    0.01
    millilitre(s)
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 34517/12-10-1999/K-0126401
Date of authorisation status change: